Cardio Diagnostics PrecisionCHD
Feb 28, 2023
Cardio Diagnostics has launched its PrecisionCHD test for detecting coronary heart disease. The test uses epigenetic and genetic biomarkers, as well as a proprietary machine-learning model, to detect heart disease in men and women. It also has an accompanying Actionable Clinical Intelligence, which maps a patient's biomarker profile onto modifiable risk factors like diabetes, hypertension, and smoking. The test can be administered in provider settings or at home with self-sampling and telehealth visits. The technology will be available exclusively for existing customers, with a nationwide rollout to follow.